NasdaqCM - Nasdaq Real Time Price USD

MetaVia Inc. (MTVA)

0.7321
+0.0011
+(0.15%)
At close: June 13 at 4:00:00 PM EDT
0.6802
-0.05
(-7.09%)
After hours: June 13 at 7:59:50 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
25,814
28,809
15,886
11,418
15,298
Operating Income
-25,814
-28,809
-15,886
-11,418
-15,298
Net Non Operating Interest Income Expense
811
920
461
-2,191
14
Other Income Expense
454
297
2,955
-358
--
Pretax Income
-24,549
-27,592
-12,470
-13,967
-15,284
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-24,549
-27,592
-12,470
-13,967
-15,284
Diluted NI Available to Com Stockholders
-24,549
-27,592
-12,470
-13,967
-15,284
Basic EPS
-2.60
--
-2.46
-43.44
-158.40
Diluted EPS
-2.60
--
-2.46
-43.44
-158.40
Basic Average Shares
9,050.8260
--
5,071.1010
321.7030
96.4320
Diluted Average Shares
9,050.8260
--
5,071.1010
321.7030
96.4320
Total Operating Income as Reported
-25,814
-28,809
-15,886
-19,628
-15,298
Total Expenses
25,814
28,809
15,886
11,418
15,298
Net Income from Continuing & Discontinued Operation
-24,549
-27,592
-12,470
-13,967
-15,284
Normalized Income
-25,003
-27,889
-15,425
-13,692
-15,284
Interest Income
811
920
461
0
14
Interest Expense
--
--
0
2,191
0
Net Interest Income
811
920
461
-2,191
14
EBIT
-25,814
-28,809
-15,886
-11,776
-15,284
EBITDA
-25,794
-28,789
-15,880
-11,756
-15,236
Reconciled Depreciation
20
20
6
20
48
Net Income from Continuing Operation Net Minority Interest
-24,549
-27,592
-12,470
-13,967
-15,284
Total Unusual Items Excluding Goodwill
454
297
2,955
-275
0
Total Unusual Items
454
297
2,955
-275
0
Normalized EBITDA
-26,248
-29,086
-18,835
-11,481
-15,236
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/5/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PALI Palisade Bio, Inc.
0.6401
-7.23%
 
CMXHF CSL Limited
148.65
-1.78%
 
MOLN Molecular Partners AG
3.8400
-1.54%
 
REVB Revelation Biosciences, Inc.
0.7940
-1.03%
 
KAPA Kairos Pharma, Ltd.
0.5200
-8.77%
 
KPRX Kiora Pharmaceuticals, Inc.
3.0200
-1.63%
 
CALC CalciMedica, Inc.
1.7200
-1.71%
 
SNSE Sensei Biotherapeutics, Inc.
0.3000
-10.58%
 
EQ Equillium, Inc.
0.3470
-10.22%
 
OKUR OnKure Therapeutics, Inc.
2.6500
-6.69%